Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Reduced adenosine uptake and its contribution to signaling that mediates profibrotic activation in renal tubular epithelial cells: implication in diabetic nephropathy.

dc.contributor.authorKretschmar, Catalina
dc.contributor.authorOyarzún, Carlos
dc.contributor.authorVillablanca, Cristopher
dc.contributor.authorJaramillo, Catherinne
dc.contributor.authorAlarcón, Sebastián
dc.contributor.authorPerez, Gustavo
dc.contributor.authorDíaz-Encarnación, Montserrat M. M.
dc.contributor.authorPastor Anglada, Marçal
dc.contributor.authorGarrido, Wallys
dc.contributor.authorQuezada, Claudia
dc.contributor.authorSan Martín, Rody
dc.date.accessioned2016-12-07T13:11:58Z
dc.date.available2016-12-07T13:11:58Z
dc.date.issued2016-01-25
dc.date.updated2016-12-07T13:12:03Z
dc.description.abstractAltered nucleoside levels may be linked to pathogenic signaling through adenosine recep- tors. We hypothesized that adenosine dysregulation contributes to fibrosis in diabetic kid- ney disease. Our findings indicate that high glucose levels and experimental diabetes decreased uptake activity through the equilibrative nucleoside transporter 1 (ENT1) in proxi- mal tubule cells. In addition, a correlation between increased plasma content of adenosine and a marker of renal fibrosis in diabetic rats was evidenced. At the cellular level, exposure of HK2 cells to high glucose, TGF- β and the general adenosine receptor agonist NECA, induced the expression of profibrotic cell activation markers α -SMA and fibronectin. These effects can be avoided by using a selective antagonist of the adenosine A 3 receptor subtype in vitro. Furthermore, induction of fibrosis marker α -SMA was prevented by the A 3 receptor antagonist in diabetic rat kidneys. In conclusion, we evidenced the contribution of purinergic signaling to renal fibrosis in experimental diabetic nephropathy.
dc.format.extent20 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec663309
dc.identifier.issn1932-6203
dc.identifier.pmid26808537
dc.identifier.urihttps://hdl.handle.net/2445/104525
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0147430
dc.relation.ispartofPLoS One, 2016, vol. 11, num. 1, p. e0147430
dc.relation.urihttps://doi.org/10.1371/journal.pone.0147430
dc.rightscc-by (c) Kretschmar, Catalina et al., 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject.classificationDiabetis
dc.subject.classificationCèl·lules epitelials
dc.subject.classificationAdenosina
dc.subject.otherDiabetes
dc.subject.otherEpithelial cells
dc.subject.otherAdenosine
dc.titleReduced adenosine uptake and its contribution to signaling that mediates profibrotic activation in renal tubular epithelial cells: implication in diabetic nephropathy.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
663309.pdf
Mida:
10.78 MB
Format:
Adobe Portable Document Format